Artal Group S.A. - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q4 2022$1,050
-99.9%
750,0000.0%0.06%
+20.4%
Q3 2022$1,155,000
-30.0%
750,0000.0%0.05%
-44.3%
Q2 2022$1,650,000
-11.3%
750,0000.0%0.09%
+12.8%
Q1 2022$1,860,000
-58.7%
750,0000.0%0.08%
-36.1%
Q4 2021$4,508,000
-9.7%
750,0000.0%0.12%
+8.9%
Q3 2021$4,995,000
+0.1%
750,0000.0%0.11%
+10.9%
Q2 2021$4,988,000
-28.2%
750,0000.0%0.10%
-17.9%
Q1 2021$6,945,000
-57.1%
750,000
-16.7%
0.12%
-64.7%
Q4 2020$16,191,000
+26.8%
900,0000.0%0.35%
+12.3%
Q3 2020$12,771,000900,0000.31%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders